The role of caveolin-1 in the biofate and efficacy of anti-tumor drugs and their nano-drug delivery systems

Canyu Yang,Bing He,Wenbing Dai,Hua Zhang,Ying Zheng,Xueqing Wang,Qiang Zhang

DOI: https://doi.org/10.1016/j.apsb.2020.11.020

IF: 14.903

2021-04-01

Acta Pharmaceutica Sinica B

Abstract:<p>As one of the most important components of caveolae, caveolin-1 is involved in caveolae-mediated endocytosis and transcytosis pathways, and also plays a role in regulating the cell membrane cholesterol homeostasis and mediating signal transduction. In recent years, the relationship between the expression level of caveolin-1 in the tumor microenvironment and the prognostic effect of tumor treatment and drug treatment resistance has also been widely explored. In addition, the interplay between caveolin-1 and nano-drugs is bidirectional. Caveolin-1 could determine the intracellular biofate of specific nano-drugs, preventing from lysosomal degradation, and facilitate them penetrate into deeper site of tumors by transcytosis; while some nanocarriers could also affect caveolin-1 levels in tumor cells, thereby changing certain biophysical function of cells. This article reviews the role of caveolin-1 in tumor prognosis, chemotherapeutic drug resistance, antibody drug sensitivity, and nano-drug delivery, providing a reference for the further application of caveolin-1 in nano-drug delivery systems.</p>

pharmacology & pharmacy

What problem does this paper attempt to address?

The paper primarily explores the role of Caveolin-1 in anti-tumor drugs and their nano drug delivery systems. Specifically, the paper attempts to address the following issues:

1. **The relationship between Caveolin-1 and tumor prognosis**:
- The relationship between the expression level of Caveolin-1 in the tumor microenvironment and the effectiveness of tumor treatment.
- The relationship between the expression level of Caveolin-1 in tumor-associated fibroblasts (CAF) and tumor prognosis.

2. **Caveolin-1 and chemotherapy drug resistance**:
- The relationship between Caveolin-1 and the resistance to small molecule chemotherapy drugs (such as 5-fluorouracil, cisplatin, etc.) in various tumor cells.
- Whether regulating the expression of Caveolin-1 can improve the effectiveness of chemotherapy drugs.

3. **Caveolin-1 and antibody drug sensitivity**:
- How the expression level of Caveolin-1 on the cell membrane affects the efficacy of antibody drugs (such as trastuzumab).
- The role of Caveolin-1 in the endocytosis process of antibody-drug conjugates (such as T-DM1) and its impact on drug sensitivity.

4. **The interaction between Caveolin-1 and nano drug delivery systems**:
- How Caveolin-1 affects the intracellular fate of specific nano drugs, preventing their lysosomal degradation, and promoting their penetration into tumor tissues.
- How some nano carriers affect the level of Caveolin-1 in tumor cells, thereby altering certain biophysical functions.

In summary, this paper aims to comprehensively elucidate the multiple mechanisms of Caveolin-1 in tumor treatment and provide a theoretical basis for the future application of nano drug delivery systems.